Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease
Edmond Teng, Carlo de Lena, Hélène Mollion, Kristin R. Wildsmith(Genentech), Terence J. O’Brien(The Royal Melbourne Hospital), Michael Dolton, Maria Carmela Tartaglia, Nawaf Yassi, Pierre Krolak‐Salmon, Oliver Peters, Reina N. Fuji, Timo Grimmer, Geoffrey A. Kerchner(Roche (Switzerland)), Pierre Anthony, Michael E. Ward(National Institutes of Health), Flávia Brunstein, Søren Nielsen, Karen Pickthorn, F. Vanhee, Ashwini Bobbala, Sandra E. Black(University College Dublin), A. Areovimata, Peter Farnbach, William Nisker, Chris Kyndt, Florence Pasquier, Annette Justesen, Andrew Frank, Richard Bergeron(Ottawa Hospital), Bali Toth, Monika Elisabeth Kottke-Arbeiter, Sietske A.M. Sikkes(Amsterdam Neuroscience), Vidya Ramakrishnan, Rik Vandenberghe(KU Leuven), Serge Belliard, Paul T. Manser, D Polívka, Christine A. F. Von Arnim(Universität Ulm), Sandra Sanabria Bohórquez, Peter Alexandersen(Center for Clinical & Basic Research), Mira Blendstrup, Frédéric Blanc, Sharon Cohen, Mathieu Ceccaldi, Bruno Dubois(Sorbonne Université), Raymond Schwartz, Siddhartha Lieten, Christoph Laske(German Center for Neurodegenerative Diseases), Giuseppe Bruno
Cited by 188
Related Papers
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
National Institute of Neurological Disorders and Stroke–Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards
|Stroke|2006|1.7k
Defeating Alzheimer's disease and other dementias: a priority for European science and society
|The Lancet Neurology|2016|1.7k
Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates
|Nature Biotechnology|2012|997
Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group
|The Lancet Neurology|2021|994